$25.95
+0.23 (+0.89%)
Open$25.92
Previous Close$25.72
Day High$26.63
Day Low$25.40
52W High$35.00
52W Low$8.00
Volume—
Avg Volume130.7K
Market Cap292.81M
P/E Ratio—
EPS$-35.44
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-69.4% upside
Current
$25.95
$25.95
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.86M | 8.97M | 49.01M |
| Net Income | -407,610,301 | -561,962,731 | -2,802,997 |
| Profit Margin | -6,960.8% | -6,612.7% | -5.7% |
| EBITDA | -69,985,584 | -101,847,893 | -4,562,575 |
| Free Cash Flow | — | — | -4,055,082 |
| Rev Growth | -34.7% | -34.7% | +7.4% |
| Debt/Equity | — | — | 0.82 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |